Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 76.23% is in line with its 5-year average of 77.54%, around the middle of its 5-year range (64.65%–82.21%).
0.10% above its 12-month average of 76.16%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-07-03): 74.55%.
GROSS MARGIN
76.23%
GROSS MARGIN AVG TTM
76.16%
GROSS MARGIN AVG 3Y
76.24%
GROSS MARGIN AVG 5Y
77.54%
GROSS MARGIN AVG 10Y
74.83%
GROSS MARGIN AVG 15Y
72.89%
GROSS MARGIN AVG 20Y
70.37%
CURRENT VS TTM AVG
+0.10%
CURRENT VS 3Y AVG
-0.01%
CURRENT VS 5Y AVG
-1.68%
CURRENT VS 10Y AVG
+1.87%
CURRENT VS 15Y AVG
+4.58%
CURRENT VS 20Y AVG
+8.32%
SECTOR MEDIAN · HEALTHCARE
41.38%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+84.22%
vs the sector median at left
STAAR Surgical Company
Market Cap
$1.11B
Gross Margin
76.23%
TTM Avg
76.16%
3Y Avg
76.24%
5Y Avg
77.54%
Market Cap
$1.12B
Gross Margin
56.01%
TTM Avg
52.19%
3Y Avg
51.27%
5Y Avg
51.81%
Market Cap
$1.12B
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.09B
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.09B
Gross Margin
75.86%
TTM Avg
76.84%
3Y Avg
76.91%
5Y Avg
76.44%
Market Cap
$1.13B
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.14B
Gross Margin
73.28%
TTM Avg
75.19%
3Y Avg
72.82%
5Y Avg
72.76%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| STAAR Surgical Company (STAA) | $1.11B | 76.23% | 76.16% | 76.24% | 77.54% |
| OPKO Health, Inc. (OPK)vs › | $1.10B | 21.10% | 32.36% | 32.56% | 33.45% |
| Replimune Group, Inc. (REPL)vs › | $1.11B | 0.00% | 0.00% | 0.00% | 0.00% |
| Tandem Diabetes Care, Inc. (TNDM)vs › | $1.12B | 56.01% | 52.19% | 51.27% | 51.81% |
| First Tracks Biotherapeutics Inc (TRAX)vs › | $1.12B | 0.00% | 0.00% | 0.00% | 0.00% |
| Bicara Therapeutics Inc. Common Stock (BCAX)vs › | $1.09B | 0.00% | 0.00% | 0.00% | 0.00% |
| IRadimed Corporation (IRMD)vs › | $1.09B | 75.86% | 76.84% | 76.91% | 76.44% |
| Avalyn Pharma Inc. Common Stock (AVLN)vs › | $1.13B | 0.00% | 0.00% | 0.00% | 0.00% |
| Harrow Health, Inc. (HROW)vs › | $1.14B | 73.28% | 75.19% | 72.82% | 72.76% |
| Amphastar Pharmaceuticals, Inc. (AMPH)vs › | $1.14B | 47.68% | 50.27% | 51.23% | 48.58% |
Gross Margin
76.2%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-07-03 | 74.55% |
| 2026-04-03 | 72.20% |
| 2026-01-02 | 75.68% |
| 2025-09-26 | 82.21% |
| 2025-06-27 | 74.00% |
| 2025-03-28 | 65.76% |
| 2024-12-27 | 64.65% |
| 2024-09-27 | 77.31% |
| 2024-06-28 | 79.20% |
| 2024-03-29 | 78.90% |
| 2023-12-29 | 79.62% |
| 2023-09-29 | 79.24% |
| 2023-06-30 | 76.62% |
| 2023-03-31 | 78.29% |
| 2022-12-30 | 77.74% |
| 2022-09-30 | 79.51% |
| 2022-07-01 | 78.76% |
| 2022-04-01 | 77.95% |
| 2021-12-31 | 76.25% |
| 2021-10-01 | 77.63% |
| 2021-07-02 | 78.89% |
| 2021-04-02 | 77.12% |
| 2021-01-01 | 74.57% |
| 2020-10-02 | 74.07% |
| 2020-07-03 | 69.42% |
| 2020-04-03 | 70.37% |
| 2020-01-03 | 74.13% |
| 2019-09-27 | 74.38% |
| 2019-06-28 | 75.38% |
| 2019-03-29 | 74.21% |
| 2018-12-28 | 73.73% |
| 2018-09-28 | 75.10% |
| 2018-06-29 | 74.40% |
| 2018-03-30 | 71.72% |
| 2017-12-29 | 69.93% |
| 2017-09-29 | 71.78% |
| 2017-06-30 | 70.54% |
| 2017-03-31 | 71.63% |
| 2016-12-30 | 71.72% |
| 2016-09-30 | 74.17% |
| 2016-07-01 | 69.73% |
| 2016-04-01 | 67.43% |
| 2016-01-01 | 70.30% |
| 2015-10-02 | 68.26% |
| 2015-07-03 | 66.25% |
| 2015-04-03 | 68.40% |
| 2015-01-02 | 56.74% |
| 2014-10-03 | 65.26% |
| 2014-07-04 | 68.17% |
| 2014-04-04 | 68.81% |
| 2014-01-03 | 68.50% |
| 2013-09-27 | 70.50% |
| 2013-06-28 | 69.48% |
| 2013-03-29 | 70.30% |
| 2012-12-28 | 67.82% |
| 2012-09-28 | 70.44% |
| 2012-06-29 | 69.28% |
| 2012-03-30 | 70.29% |
| 2011-12-30 | 69.77% |
| 2011-09-30 | 68.45% |
| 2011-07-01 | 66.76% |
| 2011-04-01 | 64.85% |
| 2010-12-31 | 64.69% |
| 2010-10-01 | 62.80% |
| 2010-07-02 | 63.63% |
| 2010-04-02 | 64.08% |
| 2010-01-01 | 55.74% |
| 2009-10-02 | 54.30% |
| 2009-07-03 | 55.78% |
| 2009-04-03 | 56.55% |
| 2009-01-02 | 57.06% |
| 2008-09-26 | 57.74% |
| 2008-06-27 | 55.81% |
| 2008-03-28 | 43.18% |
| 2007-12-28 | 50.14% |
| 2007-09-28 | 49.67% |
| 2007-06-29 | 48.47% |
| 2007-03-30 | 48.90% |
| 2006-12-29 | 43.18% |
| 2006-09-29 | 48.72% |
| 2006-06-30 | 48.35% |
| 2006-03-31 | 48.06% |
| 2005-12-30 | 45.81% |
| 2005-09-30 | 44.62% |
| 2005-07-01 | 47.52% |
| 2005-04-01 | 47.16% |
| 2004-12-31 | 47.15% |
| 2004-10-01 | 50.22% |
| 2004-07-02 | 51.15% |
| 2004-04-02 | 53.92% |
| 2004-01-02 | 56.57% |
| 2003-10-03 | 55.23% |
| 2003-07-04 | 54.48% |
| 2003-04-04 | 54.25% |
| 2003-01-03 | 51.35% |
| 2002-09-27 | 50.17% |
